Moreover, increased expression of TGR5 in the liver inhibits activation of the NLRP3 inflammasome and cleavage of caspase-1, thus alleviating inflammation and contributing to the improvement in NASH [93]. The gene discussed is GPBAR1; the disease is metabolic dysfunction-associated steatohepatitis.